ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Erythropoietin (EPO) Mediates Spontaneous Kidney Transplant Tolerance in Mice.

P. Cravedi,1 C. Purroy,1 J. Madsen,2 R. Fairchild,3 T. Tanaka,3 W. Baldwin 3rd,3 A. Alessandrini,2 P. Heeger.1

11Icahn School of Medicine at Mount Sinai, New York, NY
2Transplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA
33Department of Immunology, Cleveland Clinic Foundation, Cleveland.

Meeting: 2016 American Transplant Congress

Abstract number: 83

Keywords: Tolerance

Session Information

Session Name: Concurrent Session: Allograft Tolerance 1: Animal Models

Session Type: Concurrent Session

Date: Sunday, June 12, 2016

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:30pm-4:42pm

Location: Room 306

Spontaneous allogeneic kidney transplant tolerance occurs in mice, but the underlying mechanisms are unknown. Building upon recent human data showing that EPO, an erythropoietic hormone produced by the adult kidney, has immunosuppressive effects (JASN 2014), we tested the hypothesis that EPO is required for kidney allograft tolerance. Flow cytometric analyses showed EPO receptor expression on murine CD4+ and CD8+ T cells. Recombinant EPO inhibited T cell proliferation by 85.4±17.9% , promoted Treg induction by 148.8±39.7%, and increased Treg stability by 291.6±78.6% vs. control (p<0.05 for each). When adoptively transferred into B6 rag1-/- recipients of BALB/c (I-Ed+) kidney allografts, [sim]4% of naïve CD4+Foxp3GFPneg TEa TCR transgenic T cells spontaneously became FoxP3+, whereas <0.5% became FoxP3+ in recipients of syngeneic B6 kidney transplant controls, or in recipients of BALB/c hearts (p<0.05, n=3-5/group). Administration of recombinant EPO to B6 recipients of BALB/c hearts induced Foxp3 expression (n=3, p<0.05 vs control), treatment of kidney allograft recipients with acriflavine (a HIF-inhibitor that inhibits EPO transcription), or administration of a blocking anti-EPO mAb, prevented conversion of adoptively transferred FoxP3neg TEa cells into FoxP3+ cells (n=3-4, p<0.05 for each). We next transplanted MHC-disparate A/j kidneys or syngeneic B6 kidneys into B6 hosts (removing both recipient native kidneys). While allogeneic kidneys survived for >30 days, treatment with the anti-EPO mAb (but not an isotype control), or with acriflavine precipitated acute allograft rejection (n=5-7/group p<0.05 vs. untreated allograft recipients). Histology showed CD3 cell infiltrates with fewer FoxP3+ cells in the acriflavine or anti-EPO antibody treated A/J kidneys compared to the untreated allograft controls (p<0.05). Acriflavine treatment had no effect on control isograft survival. Together, our findings indicate that kidney allograft-produced EPO is necessary and sufficient for spontaneous allospecific Treg induction, and identify EPO as the crucial kidney-specific inducer of spontaneous kidney allograft tolerance in mice. The results provide the rationale for testing EPO as a Treg-sparing, anti-rejection therapy in humans.

CITATION INFORMATION: Cravedi P, Purroy C, Madsen J, Fairchild R, Tanaka T, Baldwin 3rd W, Alessandrini A, Heeger P. Erythropoietin (EPO) Mediates Spontaneous Kidney Transplant Tolerance in Mice. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Cravedi P, Purroy C, Madsen J, Fairchild R, Tanaka T, 3rd WBaldwin, Alessandrini A, Heeger P. Erythropoietin (EPO) Mediates Spontaneous Kidney Transplant Tolerance in Mice. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/erythropoietin-epo-mediates-spontaneous-kidney-transplant-tolerance-in-mice/. Accessed June 5, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences